论文部分内容阅读
目的:评估舍尼通治疗合并组织学前列腺炎的良性前列腺增生(BPH)患者前列腺电切术(TURP)术后仍存在的下尿路症状的疗效。方法:将接受经尿道前列腺电切术,术后病理诊断证实BPH并合并组织学前列腺炎的180例患者随机分为两组,其中A组:空白对照组90例,B组:舍尼通治疗组90例。用IPSS评分系统评估各组术后第1个月及治疗1个月后的下尿路症状。结果:A组观察1个月后和B组舍尼通治疗1个月后的IPSS评分分别为(12.04±4.73)分和(6.56±2.84)分,差异有统计学意义(P<0.001)。A组有效率2.2%,B组有效率91.1%。结论:舍尼通能明显改善合并组织学炎症的BPH患者手术后仍存在的下尿路症状,且无药物不良反应。
OBJECTIVE: To evaluate the efficacy of seneiton in the treatment of lower urinary tract symptoms after prostatectomy (TURP) in benign prostatic hyperplasia (BPH) patients with histological prostatitis. Methods: One hundred and eighty patients with BPH and histopathological prostatitis diagnosed by transurethral resection of prostate were randomly divided into two groups: group A: control group 90 cases, group B: senecton treatment Group of 90 cases. The IPSS scoring system was used to evaluate the lower urinary tract symptoms in the first month and the first month after the operation. Results: IPSS scores of group A at 1 month and group C at 1 month after treatment with corticostone were (12.04 ± 4.73) and (6.56 ± 2.84) points respectively, with statistical significance (P <0.001). The effective rate of group A was 2.2% and that of group B was 91.1%. CONCLUSIONS: Seneiton can significantly reduce the lower urinary tract symptoms that still exist in BPH patients with histological inflammation after operation, and there is no adverse drug reaction.